Some researchers found a four-fold increased risk for pancreatic cancer, a three-fold increase for stomach cancer, and a two- to three-fold increase for prostate cancer and confirmed the previously known two-fold invasive ductal BC in patients with an ATM mutation. This evidence concerns the gene ATM and breast cancer.